Movano (NASDAQ:MOVE) Upgraded at Wall Street Zen

Movano (NASDAQ:MOVE) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Movano has a consensus rating of “Sell”.

Movano Stock Up 11.0%

MOVE stock opened at $8.39 on Friday. The stock has a market cap of $6.96 million, a PE ratio of -0.77 and a beta of 0.77. The firm’s 50-day simple moving average is $8.47 and its 200 day simple moving average is $7.46. Movano has a fifty-two week low of $4.67 and a fifty-two week high of $62.80.

Movano (NASDAQ:MOVE) last posted its earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, topping the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to analysts’ expectations of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Institutional Investors Weigh In On Movano

Several hedge funds have recently bought and sold shares of MOVE. Baird Financial Group Inc. boosted its position in shares of Movano by 3.6% during the first quarter. Baird Financial Group Inc. now owns 323,943 shares of the technology company’s stock worth $593,000 after purchasing an additional 11,366 shares in the last quarter. Clayton Partners LLC raised its stake in Movano by 27.2% during the 1st quarter. Clayton Partners LLC now owns 143,476 shares of the technology company’s stock worth $263,000 after buying an additional 30,708 shares during the period. Finally, Citadel Advisors LLC acquired a new stake in Movano during the 3rd quarter worth $28,000. 16.64% of the stock is currently owned by institutional investors and hedge funds.

Key Stores Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Shareholders approved key amendments and initiatives at the recent meeting, removing a source of corporate uncertainty and enabling planned corporate actions (capital-structure or governance changes). Investors often view such approvals as clearing the way for financings or restructurings that can stabilize a micro-cap name. Movano stockholders approve key amendments and initiatives
• Neutral Sentiment: Recent analyst / media write-ups are re-examining Movano’s outlook vs. peers, highlighting valuation and business-model questions but not issuing widespread upgrades — coverage that can attract attention but is unlikely on its own to sustain a rally. Analyzing Movano (NASDAQ:MOVE) and Health Catalyst (NASDAQ:HCAT)
• Negative Sentiment: Fundamentals remain challenging: recent quarterly results showed a smaller-than-expected EPS loss relative to estimates but revenue was extremely low and the company continues to report large operating losses and negative margins — factors that keep upside speculative until revenue and cash-flow trajectories improve.
• Negative Sentiment: Market structure risk — Movano has a very small market capitalization, low average daily volume and a wide range between its 52-week low and high. That combination makes the stock prone to outsized moves on limited news or low-volume trades, increasing short-term volatility and execution risk for investors.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.